Botulinum toxin A for treating cervical dystonia

Published on 02 Sep 2019
Last Updated on 02 Sep 2019

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has recommended:

• Clostridium botulinum toxin type A neurotoxin complex (Botox) 50 U and 100 U injection vials for treating adults with cervical dystonia.

Botulinum toxin A must be administered by a neurologist trained in movement disorder or a specialist physician who has undergone training to administer botulinum toxin A to patients with movement disorders.

Subsidy status

Clostridium botulinumt oxin type A neurotoxin complex (Botox) 50 U and 100 U injection vials are recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indication.

MAF does not apply to Botox 200 U injection vial, Dysport 300 U and 500 U injection vials and Xeomin 50 U and 100 U injection vials.

Botulinum toxin A for cervical dystonia (2 Sep 2019) [PDF, 147 KB]

PES Botulinum toxin A for treating cervical dystonia (Published 2 Sep 2019) [PDF, 182 KB]